-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.00172.73% Upside
PDS Biotechnology Corporation Frequently Asked Questions
-
What analysts cover PDS Biotechnology Corporation?
PDS Biotechnology Corporation has been rated by research analysts at B.Riley Financial in the past 90 days.